# Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia

> **NCT01848145** · PHASE2 · COMPLETED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 34 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Ofatumumab

## Key facts

- **NCT ID:** NCT01848145
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-12
- **Final completion:** 2017-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01848145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01848145, "Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01848145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*